TY - JOUR
T1 - Estrogens stimulate proliferation of intrahepatic biliary epithelium in rats
AU - Alvaro, Domenico
AU - Alpini, Gianfranco
AU - Onori, Paolo
AU - Perego, Lucia
AU - Baroni, Gianluca Svegliati
AU - Franchitto, Antonio
AU - Baiocchi, Leonardo
AU - Glaser, Shannon S.
AU - Le Sage, Gene
AU - Folli, Franco
AU - Gaudio, Eugenio
PY - 2000/1/1
Y1 - 2000/1/1
N2 - Background & Aims: We investigated the expression of estrogen receptor (ER) α and β subtypes in cholangiocytes of normal and bile duct-ligated (BDL) rats and evaluated the role and mechanisms of estrogens in the modulation of cholangiocyte proliferation. Methods: ER-α and ER-β were analyzed by immunohistochemistry, reverse-transcription polymerase chain reaction, and Western blotting in normal and BDL rats. The effects of the ER antagonists tamoxifen and ICI 182, 780 on cholangiocyte proliferation were evaluated. Results: Cholangiocytes expressed both ER-α and ER-β subtypes, whereas hepatocytes expressed only ER-α. In association with a marked cholangiocyte proliferation and with enhanced estradiol serum levels, the immunoreactivity for ER-α involved a 3-fold higher percentage of cholangiocytes in 3-week BDL than in normal rats; immunore-activity for ER-β showed a 30-fold increase. Western blot analysis showed that during BDL, the total amount of ER-β in cholangiocytes was markedly increased (5-fold), whereas that of ER-α decreased slightly (-25%). Treatment with tamoxifen or ICI 182, 780 of 3-week BDL rats inhibited cholangiocyte proliferation and induced over-expression of Fas antigen and apoptosis in cholangiocytes. In vitro, 17β estradiol stimulated proliferation of cholangiocyte, an effect blocked to the same extent by tamoxifen or ICI 182, 780. Conclusions: This study suggests that estrogens and their receptors play a role in the modulation of cholangiocyte proliferation.
AB - Background & Aims: We investigated the expression of estrogen receptor (ER) α and β subtypes in cholangiocytes of normal and bile duct-ligated (BDL) rats and evaluated the role and mechanisms of estrogens in the modulation of cholangiocyte proliferation. Methods: ER-α and ER-β were analyzed by immunohistochemistry, reverse-transcription polymerase chain reaction, and Western blotting in normal and BDL rats. The effects of the ER antagonists tamoxifen and ICI 182, 780 on cholangiocyte proliferation were evaluated. Results: Cholangiocytes expressed both ER-α and ER-β subtypes, whereas hepatocytes expressed only ER-α. In association with a marked cholangiocyte proliferation and with enhanced estradiol serum levels, the immunoreactivity for ER-α involved a 3-fold higher percentage of cholangiocytes in 3-week BDL than in normal rats; immunore-activity for ER-β showed a 30-fold increase. Western blot analysis showed that during BDL, the total amount of ER-β in cholangiocytes was markedly increased (5-fold), whereas that of ER-α decreased slightly (-25%). Treatment with tamoxifen or ICI 182, 780 of 3-week BDL rats inhibited cholangiocyte proliferation and induced over-expression of Fas antigen and apoptosis in cholangiocytes. In vitro, 17β estradiol stimulated proliferation of cholangiocyte, an effect blocked to the same extent by tamoxifen or ICI 182, 780. Conclusions: This study suggests that estrogens and their receptors play a role in the modulation of cholangiocyte proliferation.
UR - http://www.scopus.com/inward/record.url?scp=0034464275&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034464275&partnerID=8YFLogxK
U2 - 10.1053/gast.2000.20184
DO - 10.1053/gast.2000.20184
M3 - Article
C2 - 11113090
AN - SCOPUS:0034464275
VL - 119
SP - 1681
EP - 1691
JO - Gastroenterology
JF - Gastroenterology
SN - 0016-5085
IS - 6
ER -